Using lisinopril to reduce harmful effects from acute radiation exposure
MITIGATION OF MULTI-ORGAN DELAYED EFFECTS OF ACUTE RADIATION EXPOSURE (DEARE) WITH ACE-INHIBITOR LISINOPRIL
This study is looking at whether lisinopril, a medicine for high blood pressure, can help reduce lung damage caused by radiation exposure in people who have experienced acute radiation syndrome.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11101189 on NIH RePORTER |
What this research studies
This research investigates the potential of lisinopril, a medication commonly used for high blood pressure, to mitigate the delayed effects of acute radiation exposure, known as DEARE. The study aims to optimize the dosage of lisinopril to effectively reduce radiation-induced lung damage and assess its efficacy in patients who have suffered from hematologic acute radiation syndrome. By leveraging previous animal studies and the established safety profile of lisinopril in humans, the research seeks to advance this treatment through the necessary regulatory processes for FDA approval.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced acute radiation exposure and are at risk for developing delayed multi-organ toxicities.
Not a fit: Patients who have not been exposed to acute radiation or those with pre-existing conditions that contraindicate the use of lisinopril may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new FDA-approved treatment option to protect patients from the long-term effects of acute radiation exposure.
How similar studies have performed: While there have been studies on the effects of lisinopril in other contexts, this specific application for mitigating DEARE is novel and has not been extensively tested.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Landrum, Jill — Medical College of Wisconsin
- Study coordinator: Landrum, Jill
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.